EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons


Journal of Clinical Investigation 73(2): 556-565
Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons
The in vitro regulation of adult human monocyte DR antigen expression was studied. Normally about 75% of freshly obtained human peripheral blood monocytes express DR antigens as determined by anti-DR and complement-mediated cytotoxicity assays. DR expression on monocytes in unfractionated peripheral blood mononuclear cell cultures persisted to variable degrees for up to 5 d of incubation. However, when the mononuclear cells were thoroughly depleted of nonadherent cells, cultured monocytes consistently exhibited progressively decreased DR expression over 2-5 d of incubation. Readdition of nonadherent cells to the adherent cell population prevented or delayed this decrease in monocyte DR antigen expression. Thus, monocyte DR expression diminished markedly during in vitro incubation; however, the presence of nonadherent cells somehow interfered with this process. In other experiments, peripheral adherent monocytes, which had been cultured for 2-3 d to reduce their DR expression, could be induced to reexpress DR antigens after 2 d of incubation with unpurified lymphokine-containing culture supernatants, recombinant human interferon-alpha, or recombinant human gamma interferon (IFN-gamma). The reinduction of DR expression on human monocytes by lymphokines was abrogated by an antiserum produced to the synthetic N-terminal amino acids of human IFN-gamma, indicating that IFN-gamma is the active mediator in the lymphokine-containing preparations. Monocytes cultured with lymphokines or recombinant interferons also could initiate a significantly greater mixed lymphocyte response than control monocytes. Thus, IFN-gamma-containing lymphokines and recombinant interferons are required to induce human monocyte DR expression and accessory cell capacity in vitro, since in their absence monocytes become DR antigen-deficient. Finally, incubation of unfractionated human mononuclear cells with anti-human IFN-gamma also promoted the loss of monocyte DR expression. These findings suggest that resting lymphocytes are probably capable of producing sufficient IFN-gamma in vitro to result in the maintenance of the monocyte DR phenotype.


Accession: 006288575

PMID: 6230374

DOI: 10.1172/JCI111243



Related references

Effect of recombinant interferons and recombinant interleukin 2 on new human mhc class i antigen expression on peripheral blood lymphocytes and leukemic cells. Immunobiology 173(2-5): 271-272, 1986

In vitro and in vivo regulation of carcinoembryonic antigen expression by recombinant human interferons. Anticancer Research 10(5 PART B): 1470-1471, 1990

In vitro and in vivo regulation of tumor antigen expression by human recombinant interferons. Nuclear Medicine & Biology 18(4): 409-412, 1991

In vitro and in vivo regulation of human tumor antigen expression by human recombinant interferons: a review. International Journal of Biological Markers 9(1): 53-60, 1994

Regulation of human peripheral blood monocyte hla dr expression following in vivo administration of recombinant interferon gamma. Federation Proceedings 44(4): 946, 1985

Phenotyping of human peripheral blood monocyte subpopulations in inflammatory dermatoses evidence for differential regulation of antigen expression in atopic dermatitis allergic contact eczema and psoriasis. Pathobiology 59(3): 178, 1991

In vitro biological responses of peripheral blood cells to recombinant human alpha beta and gamma interferons. Antiviral Research 4(SPEC ISSUE): 148, 1984

Qualitative differences in effects of recombinant alpha-, beta- and gamma-interferons on human peripheral blood leukocytes in vitro. Annales de L'institut Pasteur. Immunologie 137c(3): 259-272, 1986

Regulation of HLA class I and II expression by interferons and influenza A virus in human peripheral blood mononuclear cells. Immunology 91(3): 421-429, 1997

Regulation of HLA class I and II expression by interferons and influenza A virus in human peripheral blood mononuclear cells. Immunology 91(3): 421-429, 1997